Addus HomeCare (NASDAQ:ADUS) Given Overweight Rating at Stephens

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “overweight” rating reiterated by equities researchers at Stephens in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $115.00 target price on the stock. Stephens’ price objective suggests a potential upside of 7.39% from the stock’s current price.

ADUS has been the topic of several other research reports. Royal Bank of Canada reissued an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. Oppenheimer reissued an “outperform” rating and issued a $118.00 price target on shares of Addus HomeCare in a research report on Tuesday, March 26th. Barclays downgraded Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a report on Tuesday, April 23rd. William Blair reissued an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Finally, Bank of America boosted their price target on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday. One investment analyst has rated the stock with a sell rating and eight have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $106.57.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $107.09 on Tuesday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The firm’s 50-day moving average is $99.03 and its 200-day moving average is $92.71. Addus HomeCare has a 52-week low of $78.35 and a 52-week high of $107.54. The company has a market cap of $1.75 billion, a price-to-earnings ratio of 27.89, a PEG ratio of 1.94 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $0.97 by $0.24. The firm had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The company’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.84 EPS. Equities research analysts anticipate that Addus HomeCare will post 4.38 earnings per share for the current year.

Hedge Funds Weigh In On Addus HomeCare

A number of large investors have recently modified their holdings of ADUS. Entropy Technologies LP bought a new position in Addus HomeCare in the 1st quarter worth approximately $258,000. ProShare Advisors LLC increased its stake in shares of Addus HomeCare by 7.3% in the 1st quarter. ProShare Advisors LLC now owns 3,163 shares of the company’s stock valued at $327,000 after buying an additional 214 shares during the period. Russell Investments Group Ltd. raised its position in shares of Addus HomeCare by 9.3% during the first quarter. Russell Investments Group Ltd. now owns 46,764 shares of the company’s stock worth $4,833,000 after acquiring an additional 3,997 shares during the last quarter. TimesSquare Capital Management LLC lifted its stake in shares of Addus HomeCare by 9.8% during the first quarter. TimesSquare Capital Management LLC now owns 289,998 shares of the company’s stock valued at $29,968,000 after acquiring an additional 25,910 shares during the period. Finally, Empowered Funds LLC lifted its position in Addus HomeCare by 9.8% during the 1st quarter. Empowered Funds LLC now owns 6,890 shares of the company’s stock valued at $712,000 after purchasing an additional 615 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.